IL ACL Elite Coagulation Analyzer

Diamond Diagnostics presents the refurbished ACL Elite, a Coagulation analyzer available in a benchtop configuration, manufactured by Instrumentation Laboratory. With the capacity to perform up to 75 tests per hour and a load-up capacity of 30 samples, this analyzer is designed for efficient and accurate analysis of plasma specimens. Equipped with advanced technology, the ACL Elite delivers comprehensive insights into coagulation parameters, including clotting factors, fibrinogen levels, and platelet function assays. With up to 22 cooled reagents onboard, it ensures optimal stability and performance for sensitive coagulation assays. Its precision and reliability make it an indispensable tool in healthcare settings, providing valuable information for diagnosing and managing a wide range of bleeding disorders, thrombotic disorders, and monitoring anticoagulant therapy. Whether in hospital laboratories, clinics, or research facilities, the ACL Elite plays a crucial role in patient care by facilitating timely and accurate diagnostic results. By furnishing healthcare professionals with actionable data, it enables informed decision-making and personalized treatment strategies, ultimately contributing to improved patient outcomes and overall wellness. From routine coagulation screenings to specialized hemostasis diagnostics, the ACL Elite stands as a trusted ally in the pursuit of better healthcare, offering consistent performance and dependable results in every analysis. Coagulation analysis detects abnormalities in the components required to complete normal blood clotting. Analysis is divided into two elements; the measurement of clot timing and if the timing is abnormal, a deeper analysis to determine which factors affecting normal coagulation are deficient. Clotting disorders are either classified as Hypocoagulability, a disorder of impaired or slowed coagulation and Hypercoagulability, a disorder of unnaturally fast clotting time or manner. Hypocoagulability can result in hemorrhage or other acquired coagulation disorders such as Hemophilia while Hypercoagulability can cause unnatural clots in arteries and other vessels which could result in severe organ damage or possibly death. A balance normally exists between the factors that stimulate formation of thrombin and forces acting to delay thrombin formation. This balance maintains circulating blood as a fluid. When injury occurs or blood is removed from a blood vessel, this balance is upset, and coagulation begins. Coagulation may occur unexpectedly and internally. Symptoms for coagulation disorders are spontaneous bruising, prolonged bleeding, abnormal nosebleeds, heavy menstrual flow or gastrointestinal bleeding.